Related references
Note: Only part of the references are listed.Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL (2019)
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
F. Lynce et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors A Systematic Review and Meta-analysis
Raluca I. Mincu et al.
JAMA NETWORK OPEN (2019)
Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience
Nilesh Pareek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Immune checkpoint inhibitors and cardiovascular toxicity
Alexander R. Lyon et al.
LANCET ONCOLOGY (2018)
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
J. A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Jose Luis Zamorano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Global and regional patterns of longitudinal strain in screening for chemotherapy-induced cardiotoxicity
Guilherme Portugal et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2017)
Stress Echocardiography Positivity Predicts Cancer Death
Clara Carpeggiani et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Nazanin Aghel et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2017)
Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain
Miranda M. Fidler et al.
CIRCULATION (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer
Gregory T. Armstrong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Cancer drugs and the heart: importance and management
Thomas M. Suter et al.
EUROPEAN HEART JOURNAL (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study
Jennifer L. Patnaik et al.
BREAST CANCER RESEARCH (2011)
Cardio-Oncology/Onco-Cardiology
Robert A. Hong et al.
CLINICAL CARDIOLOGY (2010)
Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
Raoul C. Reulen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Daniela Cardinale et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
Daniela Cardinale et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cause-specific late mortality among 5-year survivors of childhood cancer: The childhood cancer survivor study
Ann C. Mertens et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Medical assessment of adverse health outcomes in long-term survivors of childhood cancer
Maud M. Geenen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Chronic health conditions in adult survivors of childhood cancer
Kevin C. Oeffinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy
D Cardinale et al.
CIRCULATION (2004)
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients
BV Jensen et al.
ANNALS OF ONCOLOGY (2002)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
